Mechanism
GLP-1 is not just a weight-loss acronym.
The biology involves receptor signaling that affects appetite, glucose-dependent insulin response, and metabolic regulation. The clinical story is powerful because it is tied to large human trials and official labels.
Regulatory split
Approved products and unapproved products are different categories.
FDA-approved semaglutide products have gone through review for specific uses. Unapproved compounded, counterfeit, or research-labeled products should not borrow that trust without evidence.
Reader value
The useful question is scope.
What is approved, what is supported by trials, what is still being studied, and what is marketing? That separation is the PeptideFactCheck lane.
Editorial boundary
What this page will not do
It will not provide dosing, cycling, sourcing, injection, or personal medical instructions. The job is to classify claims and explain mechanisms.